[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-339686-105":59,"doc-detail-339686-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","a-phase-iii-randomized-clinical-trial-comparing-laparoscopic-radical-hysterectomy-based-on-open-state-with-abdominal-radical-hysterectomy-in-patients-with-early-stage-cervical-cancer","A phase III randomized clinical trial - comparing laparoscopic radical hysterectomy based on open state with abdominal radical hysterectomy in patients with early-stage cervical cancer","","Cervical cancer remains a leading cause of cancer morbidity and mortality in women, and early-stage disease is commonly treated with radical hysterectomy plus pelvic lymph node dissection. Recent reports suggest laparoscopic surgery may yield inferior outcomes compared with traditional open approaches. This phase III, open-label, two-arm randomized single-center trial evaluates laparoscopic radical hysterectomy based on open state versus transabdominal radical hysterectomy, assessing disease-free survival and multiple secondary outcomes.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/a-phase-iii-randomized-clinical-trial-comparing-laparoscopic-radical-hysterectomy-based-on-open-state-with-abdominal-radical-hysterectomy-in-patients-with-early-stage-cervical-cancer/339686/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/a-phase-iii-randomized-clinical-trial-comparing-laparoscopic-radical-hysterectomy-based-on-open-state-with-abdominal-radical-hysterectomy-in-patients-with-early-stage-cervical-cancer/339686.png","ImageObject",300,407,{"name":92,"@type":93},"Noah","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the primary outcome of the phase III trial?","Question",{"text":113,"@type":114},"The primary aim is the rate of disease-free survival at 4.5 years.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How is the trial designed and how many participants will be enrolled?",{"text":118,"@type":114},"It is an open-label, two-armed, randomized, phase III single-center trial with 740 participants assigned 1:1 to the two treatment arms.",{"name":120,"@type":111,"acceptedAnswer":121},"What secondary outcomes will be assessed besides disease-free survival?",{"text":122,"@type":114},"Secondary aims include treatment-related morbidity, costs and cost-effectiveness, recurrence patterns, quality of life, pelvic floor function, and overall survival.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},339686,1790515439,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},8796095462418,"https://ap-avatar.wpscdn.com/avatar/80000253c1241d02b47?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778826106357471780","Zhao et al. Trials (2024) 25:471  \n[https://doi.org/10.1186/s13063-024-08318-z](https://doi.org/10.1186/s13063-024-08318-z)  \nTrials  \n STUDY PROTOCOL Open Access  \nA phase III randomized clinical trial  \ncomparing laparoscopic radical hysterectomy based on open state with abdominal radical hysterectomy in patients with early-stage cervical cancer  \nXin Zhao1, Yansong Liu 1, Jumin Niu 1 andYulin Shi1*  \nAbstract  \nBackground Cervical cancer is the fourth most frequently diagnosed cancer and the fourth leading cause of cancer death in women, The standard treatment recommendation for women with early cervical cancer is radical hysterectomy with pelvic lymph node dissection, however, articles published in recent years have concluded that the treatment outcome of laparoscopic surgery for cervical cancer is inferior to that of open surgery. Thus, we choose a surgically new approach; the laparoscopic cervical cancer surgery in the open state is compared with the traditional open cervical cancer surgery, and we hope that patients can still have a good tumor outcome and survival outcome. This trial will investigate the effectiveness of laparoscopic cervical cancer surgery in the open-state treatment of earlystage cervical cancer.  \nMethod and design This will be an open-label, 2-armed, randomized, phase-III single-center trial of comparing laparoscopic radical hysterectomy based on open state with abdominal radical hysterectomy in patients with earlystage cervical cancer. A total of 740 participants will be randomly assigned into 2 treatment arms in a 1:1 ratio. Clinical, laboratory, ultrasound, and radiology data will be collected at baseline, and then at the study assessments and procedures performed at baseline and 1 week, 6 weeks, and 3 months, and follow-up visits begin at 3 months following surgery and continue every 3 months thereafter for the first 2 years and every 6 months until year 4.5. The primary aim is the rate of disease-free survival at 4.5 years. The secondary aims include treatment-related morbidity, costs and costeffectiveness, patterns of recurrence, quality of life, pelvic floor function, and overall survival.  \nConclusions This prospective trial aims to show the equivalence of the laparoscopic cervical cancer surgery in the open state versus the transabdominal radical hysterectomy approach for patients with early-stage cervical cancer following a 2-phase protocol.  \nTrial registration ChiCTR2300075118 . Registered on August 25, 2023.  \nKeywords Cervical cancer, Laparoscopic surgery, Radical hysterectomy, Phase III clinical trial, Based on open state  \n*Correspondence:  \nYulin Shi  \n[15040291279@163.com](15040291279@163.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ()[. The Creative Commons Public Domain Dedication waiver (](http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ()[http://creativecom](http://creativecom)[mons.org/publicdomain/zero/1.0/](mons.org/publicdomain/zero/1.0/","cbCaiqsALW3CeXZU","https://ap.wps.com/l/cbCaiqsALW3CeXZU","pdf",1072463,11,"English","# Study protocol\n## Background\n## Method and design\n## Trial registration\n## Introduction\n## Previous evidence and rationale\n## Conclusions","[{\"question\":\"What is the primary outcome of the phase III trial?\",\"answer\":\"The primary aim is the rate of disease-free survival at 4.5 years.\"},{\"question\":\"How is the trial designed and how many participants will be enrolled?\",\"answer\":\"It is an open-label, two-armed, randomized, phase III single-center trial with 740 participants assigned 1:1 to the two treatment arms.\"},{\"question\":\"What secondary outcomes will be assessed besides disease-free survival?\",\"answer\":\"Secondary aims include treatment-related morbidity, costs and cost-effectiveness, recurrence patterns, quality of life, pelvic floor function, and overall survival.\"}]","A phase III randomized clinical trial - comparing laparoscopic radical hysterectomy based on open state with abdominal radical hysterectomy in patients with early-stage cervical cancer | PDF",1790031612,28,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cc89eba07c9f7bb85da9a0078695f489.webp",983,1305,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e15c483620f39e899cc49e4a4b59d99c.webp",982,1304,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a0e2d5a860ed4ab568fa8c0303ce149e.webp",981,1303,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9ac3fb9c755e3d8834de51669dabb3a4.webp",980,1301]